Tanja Bergmann
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Colorectal Cancer Treatments and Studies
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
- Surgery 2
- Pancreatic function and diabetes 1
-
- Heart Rate Variability and Autonomic Control 1
- Co-authors
- Abbas Agaimy (1 shared paper)Gerold Schuler (1 shared paper)Azadeh Tajmir-Riahi (1 shared paper)Michael Schmid (1 shared paper)Lucie Heinzerling (1 shared paper)Peter Bramlage (1 shared paper)Reinhard W. Holl (1 shared paper)Stefan Zimny (1 shared paper)
- Journals
- Diabetes Technology & Therapeutics (1 paper)Journal of Immunotherapy (1 paper)Journal of Medical Case Reports (1 paper)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
Tanja Bergmann
3 papers receiving 61 citations
Peers
Comparison fields: 5 of 18
- Oncology 53
- Cardiology and Cardiovascular Medicine 18
- Endocrinology, Diabetes and Metabolism 7
- Immunology 7
- Pulmonary and Respiratory Medicine 10
Countries citing papers authored by Tanja Bergmann
This map shows the geographic impact of Tanja Bergmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Bergmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Bergmann more than expected).
Fields of papers citing papers by Tanja Bergmann
This network shows the impact of papers produced by Tanja Bergmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Bergmann. The network helps show where Tanja Bergmann may publish in the future.
Co-authors
The 15 scholars most cited alongside Tanja Bergmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 54 | |
| 2 | 2022 | 6 | |
| 3 | 2021 | 1 |
About Tanja Bergmann
Tanja Bergmann is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Endocrine and Autonomic Systems, Oncology and Endocrinology, Diabetes and Metabolism, having authored 3 papers that have together received 61 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (1 paper), Heart Rate Variability and Autonomic Control (1 paper), Neuroscience of respiration and sleep (1 paper), Diabetes Management and Research (1 paper), CAR-T cell therapy research (1 paper), Diabetes Treatment and Management (1 paper), Advancements in Semiconductor Devices and Circuit Design (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Oncology (53 citations), Cardiology and Cardiovascular Medicine (18 citations), Endocrinology, Diabetes and Metabolism (7 citations), Immunology (7 citations) and Pulmonary and Respiratory Medicine (10 citations). Tanja Bergmann has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Abbas Agaimy, Gerold Schuler, Azadeh Tajmir-Riahi, Michael Schmid, Lucie Heinzerling, Peter Bramlage, Reinhard W. Holl, Stefan Zimny, F. Best and Svenja Meyhöfer. Their work appears in journals such as Diabetes Technology & Therapeutics, Journal of Immunotherapy and Journal of Medical Case Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.